Bluedrop Medical

Bluedrop Medical is focused on developing and commercialising a device which can predict the formation of diabetic foot ulcers. This device enables diabetic foot ulcers to be detected early when treatment is easier, and outcomes and costs greatly improve. outcomes and costs are greatly improved.

Diabetic foot ulcers are the leading cause of amputation globally. They are a big problem emotionally, clinically, and financially.

Bluedrop have developed a novel remote monitoring system based on independently proven thermal predictors of diabetic foot ulcer formation.

Other Portfolio Companies

Disclaimer

Ascentifi does not and will not provide any form of financial services or investment advice to any party. We do not promote, recommend, or sell investments. We bring start-up companies to the attention of investors. If an investor chooses to invest, we help facilitate the investment process.

The investment decisions an investor makes are the sole responsibility of the investor. Ascentifi does not assess the appropriateness of an investors investment experience and knowledge when bringing start-up companies to their attention.

Please read our full Disclaimer

Risk Warning

Investing involves risks, including total loss of capital, illiquidity, dilution, and lack of dividends. It is suitable only for investors capable of evaluating and bearing those risks.

Your investment is not covered by the deposit guarantee schemes established in accordance with Directive 2014/49/EU of the European Parliament and of the Council. Nor is your investment covered by the investor compensation schemes established in accordance with Directive 97/9/EC of the European Parliament and of the Council.

Please read our full Risk Warning